(Q53262282)

12 May 2018

title

Increased expression of CD24 is associated with tumor progression and prognosis in patients suffering osteosarcoma. (English)

1 reference

12 May 2018

1 reference

J Tang

1

1 reference

12 May 2018

H Cai

2

1 reference

12 May 2018

L Lin

3

1 reference

12 May 2018

P Xie

4

1 reference

12 May 2018

W Zhong

5

1 reference

12 May 2018

M Tang

6

1 reference

12 May 2018

publication date

10 November 2012

1 reference

12 May 2018

Clinical and Translational Oncology

published in

1 reference

12 May 2018

volume

15

1 reference

12 May 2018

issue

7

1 reference

12 May 2018

page(s)

541-547

1 reference

12 May 2018

Adjuvant chemotherapy in osteosarcoma: an odyssey of rejection and vindication

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0961-5

Prognostic markers in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0961-5

Heat stable antigen (mouse CD24) supports myeloid cell binding to endothelial and platelet P-selectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0961-5

CD24 regulates cell proliferation and transforming growth factor β-induced epithelial to mesenchymal transition through modulation of integrin β1 stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0961-5

CD24 controls Src/STAT3 activity in human tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0961-5

CD24 can be used to isolate Lgr5+ putative colonic epithelial stem cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0961-5

CD24 expression as a marker for predicting clinical outcome in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0961-5

Down regulation of CD24 and HER-2/neu in breast carcinoma cells by activated human dendritic cell. Role of STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0961-5

CD24: a novel cancer biomarker in laryngeal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0961-5

Lyn is involved in CD24-induced ERK1/2 activation in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0961-5

CD24, COX-2, and p53 in epithelial ovarian cancer and its clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0961-5

Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0961-5

Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0961-5

Involvement of CD24 in angiogenesis in a mouse model of oxygen-induced retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0961-5

A critical re-evaluation of CD24-positivity of human embryonic stem cells differentiated into pancreatic progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0961-5

Biological and clinical relevance of stem cells in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0961-5

More than markers: biological significance of cancer stem cell-defining molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0961-5

Cancer initiating cells or cancer stem cells in the gastrointestinal tract and liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0961-5

Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0961-5

CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells

21 January 2018

1 reference

12 December 2020

NDRG2 down-regulation and CD24 up-regulation promote tumor aggravation and poor survival in patients with gallbladder carcinoma

1 reference

12 December 2020

Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols

1 reference

12 December 2020

The role of CD24 in various human epithelial neoplasias

1 reference

12 December 2020

Molecular identification and targeting of colorectal cancer stem cells

1 reference

12 December 2020

Noninvasive imaging with thallium-201 scintigraphy may not correlate with survival in patients with osteosarcoma

1 reference

12 December 2020

Reduced N-Myc downstream-regulated gene 2 expression is associated with CD24 upregulation and poor prognosis in patients with lung adenocarcinoma

1 reference

12 December 2020

Expression of CD24 in cholangiocarcinoma cells is associated with disease progression and reduced patient survival

1 reference

12 December 2020

Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas

1 reference

12 December 2020

Clinical value of CD24 expression in retinoblastoma

1 reference

12 December 2020

10.1007/S12094-012-0961-5

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018